PB1727: EVALUATION OF POST-TREATMENT SECONDARY CANCERS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH MODIFIED ST. JUDE TOTAL XIII AND TOTAL XV PROTOCOLS.

MLA

Hilal Eda Korkmaz Ünlü, et al. “Pb1727: Evaluation of Post-Treatment Secondary Cancers in Children with Acute Lymphoblastic Leukemia Treated with Modified St. Jude Total Xiii and Total Xv Protocols.” HemaSphere, vol. 7, Aug. 2023. EBSCOhost, https://doi.org/10.1097/01.HS9.0000973768.84814.5b.

APA

Hilal Eda Korkmaz Ünlü, Bariş Kuşkonmaz, Şule Ünal Cangül, Melis Gültekin Bahadir, Şevkiye Selin Aytaç Eyüpoğlu, & Fatma Gümrük. (2023). Pb1727: Evaluation of Post-Treatment Secondary Cancers in Children with Acute Lymphoblastic Leukemia Treated with Modified St. Jude Total Xiii and Total Xv Protocols. HemaSphere, 7. https://doi.org/10.1097/01.HS9.0000973768.84814.5b

Chicago

Hilal Eda Korkmaz Ünlü, Bariş Kuşkonmaz, Şule Ünal Cangül, Melis Gültekin Bahadir, Şevkiye Selin Aytaç Eyüpoğlu, and Fatma Gümrük. 2023. “Pb1727: Evaluation of Post-Treatment Secondary Cancers in Children with Acute Lymphoblastic Leukemia Treated with Modified St. Jude Total Xiii and Total Xv Protocols.” HemaSphere 7 (August). doi:10.1097/01.HS9.0000973768.84814.5b.